Gardasil Update – Vaccine Adverse Events Reporting System

Examiner.com

November 10th, 2010 1:29 pm ET

The news regarding Gardisil is worrisome for parents and families. The media measures the success of the drug through monetary terms. For example: “CNN Money calls Gardasil’s crash a “design flaw” and faults the economy, puritanical parents, bad press, and Merck itself for contributing to the fallout.” I think the word ‘design flaw” is a troublesome term to use when it comes to our children. Our daughters need better concern, and protection from “design flaws.”

As of September 28, 2010, the Vaccine Adverse Events Reporting System (VAERS) has more than 18,000 Gardasil-related adverse events listed in it, including at least 65 deaths. research. As a vaccine used in the developed world, the science speaks for itself: Gardasil can’t – and never will — replace Pap smears, which are the reason that the incidence of cervical cancer is so low in the United States after decades of including pap smears in routine medical care for women. Today, cervical cancer is not even in the top 10 cancers that kill American women every year.

Another report concludes the following regarding side effects:

For example, a rough comparison of Gardasil and Menactra (a vaccine against meningitis) adverse event reports to VAERS through November 30, 2008 revealed that:

•Compared to Menactra, receipt of Gardasil is associated with at least twice as many emergency room visit reports; 4 times more death reports; 5 times more “did not recover” reports; and 7 times more “disabled” reports.
•Compared to Menactra, receipt of Gardasil is associated with all of the reports of blood clots. All 23 reports of blood clots following Gardasil occurred when Gardasil was given alone without any other vaccines.
•Compared to Menactra, receipt of Gardasil is associated with at least 4 times as many cardiac arrest reports. All 9 reports of cardiac arrest following Gardasil occurred when Gardasil was given alone without any other vaccines.
•Compared to Menactra, receipt of Gardasil is associated with at least 6 times as many fainting reports and at least 3 times as many syncope reports.
•Compared to Menactra, receipt of Gardasil is associated with at least 4 times as many lupus reports. 27 reports of lupus following Gardasil occurred when Gardasil was given alone.
•Compared to Menactra, receipt of Gardasil is associated with at least 15 times as many stroke reports. 16 reports of stroke following Gardasil occurred when Gardasil was given alone.
•Compared to Menactra, receipt of Gardasil is associated with at least 3 times as many syncope reports.
•Compared to Menactra, receipt of Gardasil is associated with at least 33 times as many thrombosis reports. 34 reports of thrombosis following Gardasil occurred when Gardasil was given alone.
•Compared to Menactra, receipt of Gardasil is associated with at least 5 times as many sasculitis reports. 11 reports of vasculitis following Gardasil occurred when Gardasiil was given alone.
•Compared to Menactra, receipt of Gardasil is associated with at least 30 times as many rechallenge reports, which involve a worsening of symptoms experienced after previous receipt of Gardasil.

More…

PG

Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.